Observational study on newly diagnosed inflammatory bowel disease patients in Norway
Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue
This study looks at how newly diagnosed inflammatory bowel disease patients in Norway are managed and how it affects their symptoms and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 16 Years to 80 Years |
| Sex | All |
| Sponsor | Helse Stavanger HF Government |
| Locations | 1 site (Stavanger) |
| Trial ID | NCT01551563 on ClinicalTrials.gov |
What this trial studies
This study focuses on the outcomes of a protocol-based management approach for patients newly diagnosed with inflammatory bowel disease (IBD) in a specific region of Norway. It is an observational study that aims to collect data on various aspects such as cytokine levels, quality of life, and fatigue assessments to generate hypotheses for future research. The study does not test a specific treatment but rather observes the natural course and management of IBD in the defined population.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have recently been diagnosed with inflammatory bowel disease.
Not a fit: Patients with a history of IBD or those unable to consent or adhere to treatment protocols may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management of IBD, potentially leading to improved patient outcomes.
How similar studies have performed: While this approach is observational and descriptive, similar studies have shown success in generating valuable insights into chronic conditions like IBD.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * newly diagnosed IBD Exclusion Criteria: * previous IBD with specific treatment within 10 year * inability to consent * inability to adhere to treatment protocol
Where this trial is running
Stavanger
- Sus — Stavanger, Norway (Recruiting)
Study contacts
- Principal investigator: Tore Grimstad, PhD — Helse Stavanger HF
- Study coordinator: tore grimstad
- Email: tore.bjorn.grimstad@sus.no
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.